Crism Therapeutics (LSE:CRTX) EPS (Basic) : £-0.02 (TTM As of Dec. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Crism Therapeutics EPS (Basic)?

Crism Therapeutics's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was £-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was £-0.02.

Crism Therapeutics's EPS (Diluted) for the six months ended in Dec. 2024 was £-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was £-0.02.

Crism Therapeutics's EPS without NRI for the six months ended in Dec. 2024 was £-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -0.07.

During the past 3 years, the average EPS without NRI Growth Rate was 44.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 35.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 20.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Crism Therapeutics's highest 3-Year average EPS without NRI Growth Rate was 44.00% per year. The lowest was -8.80% per year. And the median was 14.35% per year.

Crism Therapeutics EPS (Basic) Historical Data

The historical data trend for Crism Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Crism Therapeutics EPS (Basic) Chart

Crism Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-0.29

-0.11

-0.29

0.08

-0.02

Crism Therapeutics Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial															-0.11	-8.44	-0.01	-	-0.02

Crism Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Crism Therapeutics's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.607	-	0)	/	32.181
	=	-0.02

Crism Therapeutics's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-0.594	-	0)	/	32.181
	=	-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.02

Crism Therapeutics (LSE:CRTX) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Crism Therapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Crism Therapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Crism Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Crism Therapeutics Corp (LSE:CRTX) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kingston Chambers, P.O. Box 173, Tortola, Road Town, VGB

Website

https://www.crismtherapeutics.com

Crism Therapeutics Corp has developed a drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs. Its product ChemoSeed which is in its clinical trial phase, can be implanted directly into the tumour or the resection margin following the removal of a tumour. The company also provides consultancy and formulation services to its clients assisting them with pharmaceutical formulation and development.

Crism Therapeutics Headlines

No Headlines